UC San Diego Sulpizio Cardiovascular Center is now offering patients with atrial fibrillation the breakthrough benefits of heat energy, or radio frequency waves, to irreversibly alter heart tissue that triggers an abnormal heart rhythm or arrhythmia. The THERMOCOOL SF Catheter is an FDA-approved outpatient procedure for an early-stage form of the condition called paroxysmal atrial fibrillation, when recurring symptoms are unresponsive to medicine. Patients typically experience rapid heartbeats that can lead to debilitating fatigue, dizziness, fainting or shortness of breath if left untreated.
- Literature - 09:00 A Book of Strange and Wonderful Tales and its Eminent Translator
- Life Sciences - Dec 19 Stanford chemists take step toward solving mystery of how enzymes work
- Medicine - Dec 19 Ways to improve public health at beaches
- Social Sciences - Dec 19 Strong neighborhood ties can help reduce gun violence
- Medicine - Dec 19 Imperial strengthens senior health leadership roles
- Physics - Dec 19 Dynamic New App for Learning About Particle Physics Now Available
- Medicine - Dec 19 U of T's great cities stories of 2014: the year in review
- Life Sciences - Dec 19 Lost memories might be able to be restored, new UCLA study indicates
- Computer Science - Dec 19 Prime Minister learns how Lancaster University technology protects children online
- Business - Dec 19 Diverse ideas served up at first food systems summit
- Mechanical Engineering - Dec 19 Shaping the future of aviation
- Social Sciences - Dec 19 Vitamin D link to short- sightedness ruled out
- Environmental Sciences - Dec 19 Weighing risks and rewards, pregnant women eat less fish
- Astronomy - Dec 19 Satellites guide sailor from treacherous waters
- Medicine - Dec 19 Jason Moore Named Director of the Institute for Biomedical Informatics at Penn Medicine
- Medicine - Dec 19 Effective Treatment for Type 1 Diabetes Patients with Severe Hypoglycemia
UCSD Uses Heat Energy to Fix Odd Heart Beat
"Atrial fibrillation has a devastating impact on more than 2.7 million Americans, yet for many patients unresponsive to medication, traditional treatment options are limited," said Gregory Feld, MD, professor of medicine at University of California, San Diego and Director of the Cardiac Electrophysiology Program at UC San Diego Sulpizio Cardiovascular Center. "This catheter ablation technology is the latest treatment alternative for patients dealing with the disabling effects of cardiac arrhythmias, such as paroxysmal atrial fibrillation. This is a viable option for patients who do not benefit from their first medication."
Atrial fibrillation causes the upper heart chambers to beat rapidly and uncontrollably, and is characterized by disorganized electrical activity in the heart. This results in an irregular pulse, and sometimes a "fluttering" feeling in the chest. An episode can last just seconds, or occur for minutes, hours or even days. Paroxysmal atrial fibrillation is an early-stage form of the condition, where episodes occur repeatedly but stop on their own, often in a few hours or less.
Performed by an electrophysiologist (EP), catheter ablation is a non-surgical procedure that addresses the underlying cause of arrhythmias. In real time, the clinician first pinpoints the source of irregular electrical activity using a 3-D mapping system, similar to a GPS device in your car. Guided by this map, the clinician directs a specialized catheter through the heart to the source of the abnormal electrical impulses. A small electrode in the tip of the catheter generates radio frequency waves that have enough heat to alter targeted areas of heart tissue. This process blocks the electrical impulses that can cause heart rhythm disorders.
Unlike traditional catheter technologies, the THERMOCOOL SF catheter uniformly delivers a cooling saline solution through the catheter, allowing for cooling of the entire catheter tip. Thus, the tip temperature does not rise significantly during ablation, which reduces the risk for clotting, and enhances treatment safety.
This outpatient procedure takes approximately two-to-four hours, with some patients returning home the next day. The result is either a long-term reduction in the number of arrhythmias experienced and the severity of symptoms, or a permanent return to a more normal heart rhythm.
Atrial fibrillation is growing in prevelance. Up to 12 million Americans will have the condition by 2050. While not life-threatening, atrial fibrillation is a leading cause of stroke among people 65 years and older.
Last job offers
- Arts - 18.12
Vizedirektorin / Vizedirektor Lehre
- Administration - 18.12
SNI Outreach Manager (f/m)
- Agronomy - 18.12
PhD position (m/f) in plant ecology
- Business - 17.12
Dozenten / Dozentin und Studiengangsleiter/in im Bereich Leadership und HR Development
- Medicine - 16.12
Lecturer / Senior Lecturer (Cytometry) PhD Position
- Literature - 15.12
Professeur-e assistant-e en littérature italienne moderne et contemporaine
- Literature - 19.12
Chair of Spanish language and culture (1, 0 fte)
- Business - 19.12
Assistant Professor of Economics, with a focus on Organisational Economics (1, 0 fte)
- Computer Science - 3.12
Universitätsprofessur für Informatik und deren Didaktik am Institut für Informatikdidaktik
- Mathematics - 3.12
Full Professor of Stochastic Processes at the Department of Statistics
- Computer Science - 19.12
Vertretungsprofessur für Theoretische Informatik
- Business - 19.12
- Life Sciences - 19.12
Assistant / Associate Professor in Ruminant Nutrition
- Medicine - 19.12
Professorship of Neurology
- Medicine - 20.12
General Internal Medicine - Assistant Professor WOT (AA9485)
- Medicine - 20.12
Cardiology - Assistant, Associate or Full Professor WOT (AA9502)